Tag: pharmaceuticals
-

NIH Funding Nanodrugs to Prevent Opioid Addiction
A drug that invokes the immune system to block addictive effects of opioid pain drugs and heroin is in early development at Washington University in St. Louis.
-

Gates Supporting Infectious Antibody Discovery
The Bill and Melinda Gates Foundation is enlisting a company that discovers therapeutic antibodies to help researchers develop new drugs and vaccines for serious infectious diseases.
-

Microsoft, Biotech Partner on Gene, Cell Therapies
A biotechnology company in the U.K. and U.S. software maker Microsoft are collaborating on new processes to speed development of gene and cell therapies.
-

Trial Shows Engineered Plant Product Heals Wounds
A small-scale clinical trial shows synthetic human collagen derived from engineered tobacco plants promotes closure of lower-limb wounds, often difficult to heal.
-

Commentary – Scott Gottlieb’s Legacy
During his tenure, FDA issued a number of guidance documents outlining regulatory processes and practices that streamline reviews, yet are still dictated by scientific evidence.
-

Univ. Developing Implanted Islet Cell Bags for Diabetes
Implantable collections of insulin-producing islet cells resembling tea bags, for people with type 1 diabetes, are being developed by researchers at University of Arizona.
-

Trial Testing Targeted Solid Tumor Immunotherapy
A clinical trial is underway testing the safety of a cancer therapy that harnesses the immune system, but also works only in the tumor to reduce adverse side effects.
-

Skin Bacteria Therapy Tested in Kids with Eczema
A clinical trial is underway testing a form of bacteria sprayed on the skin that oxidize ammonia as a treatment for atopic dermatitis, or eczema, in children and teens.
-

Biogen Acquires Gene Therapy Company in $800M Deal
A company developing treatments for inherited eye diseases that replace malfunctioning with healthy genes is being acquired by biotechnology company Biogen.
-

Infographic – Fastest Growing Measles Outbreaks
Measles, a disease once considered by health authorities to be under control, is making a comeback in many places in the world.